Roidipedia.Compound reference & reporting
06 AUG 2026
CompoundsResearch chemical 2C-T-4
Research chemicalResearch chemicalPhenethylaminePsychedelic

2C-T-4

Also known as 2,5-dimethoxy-4-isopropylthiophenethylamine

2C-T-4 is a 2C-T-series psychedelic phenethylamine with a 4-isopropylthio group. It is potent and long-acting with a strong visual and introspective profile, and — like other 2C-T thioethers — carries a specific risk of dangerous interaction with MAOIs.

01 Overview

2C-T-4 (2,5-dimethoxy-4-isopropylthiophenethylamine) belongs to the sulfur-substituted 2C-T family. It is reported as strongly psychedelic and introspective with a long duration, often 10-15 hours, and a slow, sometimes plateauing onset.

Human evidence is anecdotal. The defining safety concern for the 2C-T thioethers is that they are metabolised by monoamine oxidase; combining them with MAO inhibitors (including some antidepressants and harmala alkaloids) has been linked to serious and potentially fatal reactions. This interaction risk sets the 2C-T series apart from other 2C compounds.

02 Mechanism

Serotonin 5-HT2A receptor agonist; the alkylthio group at the 4 position confers potency, and metabolism by monoamine oxidase underlies the MAOI interaction hazard.

03 Dosing

TierDoseRouteNotes
Threshold5–8 mgOral
Common8–20 mgOralAnecdotal range.
Strong20–30 mgOral

04 Effects

EffectMagnitudeEvidence
Strong visualsRich visual patterning building slowly.Anecdotal
IntrospectionDeep, feeling-oriented headspace.Anecdotal
Very long durationExtended experience with slow onset.10-15 hAnecdotal

05 Side effects

EffectSeverityFrequencyEvidenceCountermeasures
NauseaOnset-phase queasiness, sometimes pronounced.ModerateCommonAnecdotal
AnxietyAnxiety amplified by long duration and slow onset.ModerateDose-dependentAnecdotal
Dangerous MAOI interactionCombining 2C-T thioethers with monoamine oxidase inhibitors has been associated with severe, potentially fatal reactions.Life-threateningRare but severeObservational

07 References

2C-T series pharmacology and MAOI interaction cautionsPiHKAL / community harm-reduction summaries

08 Discussion0 comments

?
Sign in to add a comment…
Create account
Discussion is moderated. No sourcing, vendor names or price talk — those comments are removed, and repeat posts are banned.
This page is reference information, not medical advice. Doses and protocols are documented as they appear in the clinical literature and in practice — describing them is not a recommendation to use them. Countermeasures listed here are not a substitute for a physician. Legal status varies by jurisdiction and changes.